Email Updates
Back
Malone, Daniel C.
Malone, Daniel C.
Risk of bleeding with exposure to warfarin and nonsteroidal anti-inflammatory drugs: a systematic review and meta-analysis.
Citation:
Villa Zapata L, Hansten PD, Panic J, Horn JR, Boyce RD, Gephart S, Subbian V, Romero A, Malone DC. Risk of bleeding with exposure to warfarin and nonsteroidal anti-inflammatory drugs: a systematic review and meta-analysis. Thromb Haemost. 2020 Jul;120(7):1066-1074. doi: 10.1055/s-0040-1710592. Epub 2020 May 26. PMID: 32455439.
Principal Investigator:
Evidence of clinically meaningful drug-drug interaction with concomitant use of colchicine and clarithromycin.
Citation:
Villa Zapata L, Hansten PD, Horn JR, Boyce RD, Gephart S, Subbian V, Romero A, Malone DC. Evidence of clinically meaningful drug-drug interaction with concomitant use of colchicine and clarithromycin. Drug Saf. 2020 Jul;43(7):661-668. doi: 10.1007/s40264-020-00930-7. PMID: 32274687.
Principal Investigator:
Project Name:
Enabling Shared Decision Making to Reduce Harm from Drug Interactions: An End-to-End Demonstration
Description:
This research will develop and disseminate sharable, interoperable drug-drug interaction decision-making tools that enable patient-centered shared decision making.
Principal Investigator:
Project Dates:
September 30, 2019 to September 29, 2021
Dissemination and Implementation of QT Risk Clinical Decision Support
Description:
This research will further disseminate a currently used clinical decision support tool to identify patients at risk for a life threatening, uncommon cardiac arrhythmia.
Principal Investigator:
Project Dates:
April 1, 2019 to March 31, 2022
Meaningful Drug Interaction Alerts
Description:
This project proposes a novel proactive system to reduce alert burden and thereby increase attention to situations in which patient safety is at risk.
Principal Investigator:
Project Dates:
May 1, 2018 to February 28, 2022
Individualized Drug Interaction Alerts - Final Report
Citation:
Malone D. Individualized Drug Interaction Alerts - Final Report. (Prepared by the University of Arizona under Grant No. R21 HS023826). Rockville, MD: Agency for Healthcare Research and Quality, 2017.
Principal Investigator:
Project Name:
Individualized Drug Interaction Alerts
Description:
This project developed patient-tailored relevant warnings about drug-drug interactions and found that it reduced irrelevant alerts.
Principal Investigator:
Project Dates:
July 1, 2015 to June 30, 2017
